Abbott Laboratories

ABBOTT LABORATORIES

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Massachusetts,,Usa,-,26,July,2024.,Bank,Of,America,Logo

Earnings

Equities

Markets

ASML

PZZA

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este miércoles: BAC, PZZA, MS, ASML y ABT.

5 acciones en el foco este miércoles: BAC, PZZA, MS, ASML y ABT

Gradient,Of,Fabric,Usa,American,And,Eu,European,Union,Flags,

News

General

TSLA

EE.UU. y la UE negocian eliminar aranceles industriales. Exportadores como Caterpillar, Boeing, Tesla y Pfizer serían los más beneficiados.

EE.UU. y UE avanzan hacia un acuerdo arancelario: impacto en Caterpillar, Boeing y Tesla

Time magazine

Long Ideas

Tech

Media

Trading Ideas

AMZN

BABA

BYDDF

BYDDY

CMCSA

COIN

COUR

CRSP

DASH

DUOL

ENGIY

EQNR

ESLOY

GILD

GOOG

GOOGL

HYMTF

LRLCY

MELI

MSFT

NFLX

NTDOY

ONON

PLTR

PMRTY

SFTBF

SFTBY

UMGNF

UNVGY

TIME revela las 100 empresas más influyentes de 2025. Conoce las compañías en bolsa que lideran innovación y crecimiento este año.

Las empresas más influyentes de 2025 según TIME: ¿Cuáles están en bolsa?

American Bitcoin Corp. - Class A Common Stock

American Bitcoin Corp

Arcblock - United States dollar

Abits Group Inc

ALTEROLA BIOTECH INC by Alterola Biotech, Inc.

Alterola Biotech Inc

AB&T Financial Corp Com

ABOITIZ EQTY VNT UNSP/ADR by Aboitiz Equity Ventures, Inc.

Aboitiz Equity Ventures Inc

Press Releases

Abbott's Latest-Generation FreeStyle Libre 3 Plus Glucose Sensor Technology Launches in Canada

Small Cap

Opinion

Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity

Ainnova Tech Reaches Major FDA Milestone in AI-Powered Diabetic Retinopathy Detection

Abbott Reports Second-Quarter 2025 Results

Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season

NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings

Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis

Dividends

Abbott Declares 407th Consecutive Quarterly Dividend

Abbott Hosts Conference Call for Third-Quarter Earnings

Abbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee

AVAI

DXCM

IRTC

TNDM

Baxter Intl

Becton, Dickinson and Company Common Stock

Becton Dickinson

Boston Scientific Corporation Common Stock

Boston Scientific

DexCom

Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences

GE HealthCare Technologies Inc. - Common Stock

GE HealthCare Techs

Glaukos

Globus Medical, Inc. Class A Common Stock

Globus Medical

Hologic

IDEXX Laboratories

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies

Intuitive Surgical

Integer Holdings Corporation Common Stock

Integer Holdings

Masimo

Medtronic

Penumbra

Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips

Insulet

ResMed

Smith & Nephew

Steris

Stryker

Teleflex

TransMedics Group

Zimmer Biomet Holdings, Inc. Common Stock

Zimmer Biomet Holdings

Benchmark

Evercore ISI Group

Citigroup

Wells Fargo

Raymond James

Screenshot 2025-02-24 at 11.35.34 PM

Biotech

BRTX

BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease

Screenshot 2025-02-24 at 6.22.23 PM

GCTK

Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial

Screenshot 2024-12-03 at 7.43.04 PM

Driving Innovation In Diabetes Management: Glucotrack Begins Enrollment For Human Clinical Trials For Its Implantable Continuous Blood Glucose Monitor

Screenshot 2024-10-03 at 5.30.47 PM

Health Care

SENS

Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology

Movers & Shakers

Continuous Blood Glucose Monitoring Can Materially Improve The Quality Of Life For People With Diabetes – Glucotrack Wants To Make It Easier

Comments

Abbott Laboratories

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL